News

Filter

Current filters:

SpirogenPharmaceutical

Briefs: Ablynx inks research deal with Spirogen; Solent Pharma debuts

25-02-2013

Belgium drug developer Ablynx (Euronext Brussels: ABLX]) has entered into a research collaboration with…

AblynxGenericsidebenoneIdecortexLicensingMarkets & MarketingNeurologicalOncologyPharmaceuticalResearchSolent PharmaSpirogen

Celtic Therapeutics sets up $50 million Swiss ADC company

26-03-2012

USA-based private equity firm Celtic Therapeutics Management has announced a significant commitment to…

ADC TherapeuticsBiotechnologyCancer Research TechnologyCeltic TherapeuticsFinancialOncologyPharmaceuticalResearchSpirogen

COMPANY SPOTLIGHT

Menarini

Back to top